The award is intended to support the discovery of a novel series of potent compounds targeting drug abuse and alleviate pain.
Dalton Medicinal Chemistry co-founder Judd Berman said, "It is exceptionally exciting to receive notice of this competitive award from National Institute On Drug Abuse (NIDA) which germinated from the creative insights of the talented scientists at Dalton."
Dalton offers medicinal chemistry capabilities in design and synthesis of new chemical entities.